nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—leg—chronic obstructive pulmonary disease	0.0221	0.189	CbGeAlD
Risedronate—FDPS—respiratory system—chronic obstructive pulmonary disease	0.0143	0.123	CbGeAlD
Risedronate—FDPS—connective tissue—chronic obstructive pulmonary disease	0.0126	0.108	CbGeAlD
Risedronate—FDPS—bronchus—chronic obstructive pulmonary disease	0.0118	0.101	CbGeAlD
Risedronate—FDPS—smooth muscle tissue—chronic obstructive pulmonary disease	0.0115	0.0988	CbGeAlD
Risedronate—FDPS—trachea—chronic obstructive pulmonary disease	0.0106	0.0906	CbGeAlD
Risedronate—FDPS—lung—chronic obstructive pulmonary disease	0.00759	0.0651	CbGeAlD
Risedronate—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.00548	0.047	CbGeAlD
Risedronate—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.00483	0.0414	CbGeAlD
Risedronate—PTGS2—bronchus—chronic obstructive pulmonary disease	0.00451	0.0387	CbGeAlD
Risedronate—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00441	0.0379	CbGeAlD
Risedronate—PTGS2—trachea—chronic obstructive pulmonary disease	0.00405	0.0347	CbGeAlD
Risedronate—PTGS2—lung—chronic obstructive pulmonary disease	0.00291	0.025	CbGeAlD
Risedronate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.00149	CcSEcCtD
Risedronate—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.00131	0.00148	CcSEcCtD
Risedronate—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.00131	0.00148	CcSEcCtD
Risedronate—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00148	CcSEcCtD
Risedronate—Cataract—Prednisone—chronic obstructive pulmonary disease	0.0013	0.00147	CcSEcCtD
Risedronate—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00147	CcSEcCtD
Risedronate—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00147	CcSEcCtD
Risedronate—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00147	CcSEcCtD
Risedronate—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00145	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00144	CcSEcCtD
Risedronate—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00126	0.00143	CcSEcCtD
Risedronate—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00142	CcSEcCtD
Risedronate—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00142	CcSEcCtD
Risedronate—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00142	CcSEcCtD
Risedronate—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00142	CcSEcCtD
Risedronate—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00142	CcSEcCtD
Risedronate—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.00124	0.0014	CcSEcCtD
Risedronate—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00123	0.0014	CcSEcCtD
Risedronate—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00139	CcSEcCtD
Risedronate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00137	CcSEcCtD
Risedronate—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0012	0.00136	CcSEcCtD
Risedronate—Cough—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00136	CcSEcCtD
Risedronate—Cough—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00136	CcSEcCtD
Risedronate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00135	CcSEcCtD
Risedronate—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00135	CcSEcCtD
Risedronate—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00135	CcSEcCtD
Risedronate—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00135	CcSEcCtD
Risedronate—Cough—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00133	CcSEcCtD
Risedronate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.00133	CcSEcCtD
Risedronate—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00133	CcSEcCtD
Risedronate—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00133	CcSEcCtD
Risedronate—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00133	CcSEcCtD
Risedronate—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00133	CcSEcCtD
Risedronate—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00133	CcSEcCtD
Risedronate—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00133	CcSEcCtD
Risedronate—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00132	CcSEcCtD
Risedronate—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00132	CcSEcCtD
Risedronate—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00132	CcSEcCtD
Risedronate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.00132	CcSEcCtD
Risedronate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.00132	CcSEcCtD
Risedronate—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00132	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00132	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00132	CcSEcCtD
Risedronate—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00115	0.0013	CcSEcCtD
Risedronate—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00115	0.0013	CcSEcCtD
Risedronate—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.0013	CcSEcCtD
Risedronate—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00115	0.0013	CcSEcCtD
Risedronate—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00114	0.0013	CcSEcCtD
Risedronate—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00129	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00129	CcSEcCtD
Risedronate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00129	CcSEcCtD
Risedronate—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00128	CcSEcCtD
Risedronate—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00128	CcSEcCtD
Risedronate—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00127	CcSEcCtD
Risedronate—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00127	CcSEcCtD
Risedronate—Infection—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00126	CcSEcCtD
Risedronate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00126	CcSEcCtD
Risedronate—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00125	CcSEcCtD
Risedronate—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00125	CcSEcCtD
Risedronate—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00125	CcSEcCtD
Risedronate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00111	0.00125	CcSEcCtD
Risedronate—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00125	CcSEcCtD
Risedronate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00125	CcSEcCtD
Risedronate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00125	CcSEcCtD
Risedronate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00125	CcSEcCtD
Risedronate—Infection—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00124	CcSEcCtD
Risedronate—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00124	CcSEcCtD
Risedronate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00124	CcSEcCtD
Risedronate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00124	CcSEcCtD
Risedronate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00123	CcSEcCtD
Risedronate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00123	CcSEcCtD
Risedronate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00122	CcSEcCtD
Risedronate—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.00122	CcSEcCtD
Risedronate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00121	CcSEcCtD
Risedronate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00119	CcSEcCtD
Risedronate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00118	CcSEcCtD
Risedronate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00118	CcSEcCtD
Risedronate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00118	CcSEcCtD
Risedronate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00117	CcSEcCtD
Risedronate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00116	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00116	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00116	CcSEcCtD
Risedronate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00115	CcSEcCtD
Risedronate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00115	CcSEcCtD
Risedronate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00114	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.001	0.00114	CcSEcCtD
Risedronate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.001	0.00113	CcSEcCtD
Risedronate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00113	CcSEcCtD
Risedronate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000996	0.00113	CcSEcCtD
Risedronate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00099	0.00112	CcSEcCtD
Risedronate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00099	0.00112	CcSEcCtD
Risedronate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000989	0.00112	CcSEcCtD
Risedronate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000986	0.00112	CcSEcCtD
Risedronate—Injury—Prednisone—chronic obstructive pulmonary disease	0.000979	0.00111	CcSEcCtD
Risedronate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000977	0.00111	CcSEcCtD
Risedronate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000971	0.0011	CcSEcCtD
Risedronate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000971	0.0011	CcSEcCtD
Risedronate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000969	0.0011	CcSEcCtD
Risedronate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000969	0.0011	CcSEcCtD
Risedronate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000969	0.0011	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000967	0.00109	CcSEcCtD
Risedronate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000961	0.00109	CcSEcCtD
Risedronate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000961	0.00109	CcSEcCtD
Risedronate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000961	0.00109	CcSEcCtD
Risedronate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000961	0.00109	CcSEcCtD
Risedronate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00096	0.00109	CcSEcCtD
Risedronate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000953	0.00108	CcSEcCtD
Risedronate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000951	0.00108	CcSEcCtD
Risedronate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000949	0.00107	CcSEcCtD
Risedronate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000946	0.00107	CcSEcCtD
Risedronate—Pain—Montelukast—chronic obstructive pulmonary disease	0.000942	0.00107	CcSEcCtD
Risedronate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000939	0.00106	CcSEcCtD
Risedronate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000934	0.00106	CcSEcCtD
Risedronate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000931	0.00105	CcSEcCtD
Risedronate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000931	0.00105	CcSEcCtD
Risedronate—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000928	0.00105	CcSEcCtD
Risedronate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000925	0.00105	CcSEcCtD
Risedronate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000921	0.00104	CcSEcCtD
Risedronate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000919	0.00104	CcSEcCtD
Risedronate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000919	0.00104	CcSEcCtD
Risedronate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000916	0.00104	CcSEcCtD
Risedronate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000915	0.00104	CcSEcCtD
Risedronate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000908	0.00103	CcSEcCtD
Risedronate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000908	0.00103	CcSEcCtD
Risedronate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.0009	0.00102	CcSEcCtD
Risedronate—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.0009	0.00102	CcSEcCtD
Risedronate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000893	0.00101	CcSEcCtD
Risedronate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000893	0.00101	CcSEcCtD
Risedronate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000889	0.00101	CcSEcCtD
Risedronate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000889	0.00101	CcSEcCtD
Risedronate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000889	0.00101	CcSEcCtD
Risedronate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000889	0.00101	CcSEcCtD
Risedronate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000886	0.001	CcSEcCtD
Risedronate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000878	0.000994	CcSEcCtD
Risedronate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000878	0.000993	CcSEcCtD
Risedronate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000877	0.000993	CcSEcCtD
Risedronate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000875	0.00099	CcSEcCtD
Risedronate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000873	0.000988	CcSEcCtD
Risedronate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000871	0.000985	CcSEcCtD
Risedronate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000871	0.000985	CcSEcCtD
Risedronate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000868	0.000983	CcSEcCtD
Risedronate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000861	0.000975	CcSEcCtD
Risedronate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000857	0.00097	CcSEcCtD
Risedronate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000843	0.000955	CcSEcCtD
Risedronate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000839	0.00095	CcSEcCtD
Risedronate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000839	0.00095	CcSEcCtD
Risedronate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000828	0.000938	CcSEcCtD
Risedronate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000828	0.000938	CcSEcCtD
Risedronate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000827	0.000937	CcSEcCtD
Risedronate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000811	0.000918	CcSEcCtD
Risedronate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000807	0.000913	CcSEcCtD
Risedronate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000807	0.000913	CcSEcCtD
Risedronate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000795	0.0009	CcSEcCtD
Risedronate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000795	0.0009	CcSEcCtD
Risedronate—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000794	0.000899	CcSEcCtD
Risedronate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00079	0.000894	CcSEcCtD
Risedronate—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000783	0.000887	CcSEcCtD
Risedronate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000782	0.000885	CcSEcCtD
Risedronate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000779	0.000882	CcSEcCtD
Risedronate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000769	0.000871	CcSEcCtD
Risedronate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000769	0.000871	CcSEcCtD
Risedronate—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000766	0.000867	CcSEcCtD
Risedronate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000762	0.000862	CcSEcCtD
Risedronate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000753	0.000853	CcSEcCtD
Risedronate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000751	0.00085	CcSEcCtD
Risedronate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000743	0.000842	CcSEcCtD
Risedronate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000743	0.000842	CcSEcCtD
Risedronate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000728	0.000824	CcSEcCtD
Risedronate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000726	0.000822	CcSEcCtD
Risedronate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000715	0.000809	CcSEcCtD
Risedronate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000715	0.000809	CcSEcCtD
Risedronate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000709	0.000802	CcSEcCtD
Risedronate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000709	0.000802	CcSEcCtD
Risedronate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000708	0.000802	CcSEcCtD
Risedronate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000708	0.000802	CcSEcCtD
Risedronate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000704	0.000797	CcSEcCtD
Risedronate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000704	0.000797	CcSEcCtD
Risedronate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000702	0.000795	CcSEcCtD
Risedronate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.0007	0.000793	CcSEcCtD
Risedronate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000694	0.000786	CcSEcCtD
Risedronate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000694	0.000785	CcSEcCtD
Risedronate—Depression—Prednisone—chronic obstructive pulmonary disease	0.000692	0.000783	CcSEcCtD
Risedronate—Headache—Montelukast—chronic obstructive pulmonary disease	0.00069	0.000781	CcSEcCtD
Risedronate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000682	0.000772	CcSEcCtD
Risedronate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.000764	CcSEcCtD
Risedronate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00067	0.000759	CcSEcCtD
Risedronate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000669	0.000758	CcSEcCtD
Risedronate—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000669	0.000757	CcSEcCtD
Risedronate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000669	0.000757	CcSEcCtD
Risedronate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000668	0.000756	CcSEcCtD
Risedronate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000668	0.000756	CcSEcCtD
Risedronate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000665	0.000753	CcSEcCtD
Risedronate—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000656	0.000742	CcSEcCtD
Risedronate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000654	0.00074	CcSEcCtD
Risedronate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000644	0.000729	CcSEcCtD
Risedronate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000631	0.000714	CcSEcCtD
Risedronate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000626	0.000709	CcSEcCtD
Risedronate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000623	0.000705	CcSEcCtD
Risedronate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000612	0.000693	CcSEcCtD
Risedronate—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000599	0.000678	CcSEcCtD
Risedronate—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000582	0.000659	CcSEcCtD
Risedronate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000565	0.00064	CcSEcCtD
Risedronate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000562	0.000637	CcSEcCtD
Risedronate—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000556	0.00063	CcSEcCtD
Risedronate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000551	0.000623	CcSEcCtD
Risedronate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000547	0.000619	CcSEcCtD
Risedronate—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000546	0.000618	CcSEcCtD
Risedronate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000542	0.000614	CcSEcCtD
Risedronate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000521	0.000589	CcSEcCtD
Risedronate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000501	0.000567	CcSEcCtD
Risedronate—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000495	0.000561	CcSEcCtD
Risedronate—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000487	0.000551	CcSEcCtD
Risedronate—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000486	0.00055	CcSEcCtD
Risedronate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000484	0.000548	CcSEcCtD
Risedronate—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000476	0.000539	CcSEcCtD
Risedronate—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000468	0.00053	CcSEcCtD
Risedronate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000462	0.000522	CcSEcCtD
Risedronate—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000462	0.000522	CcSEcCtD
Risedronate—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00046	0.000521	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000458	0.000519	CcSEcCtD
Risedronate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000449	0.000508	CcSEcCtD
Risedronate—Infection—Prednisone—chronic obstructive pulmonary disease	0.00044	0.000498	CcSEcCtD
Risedronate—Shock—Prednisone—chronic obstructive pulmonary disease	0.000435	0.000493	CcSEcCtD
Risedronate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000434	0.000491	CcSEcCtD
Risedronate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00043	0.000486	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000403	0.000456	CcSEcCtD
Risedronate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000403	0.000456	CcSEcCtD
Risedronate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.0004	0.000453	CcSEcCtD
Risedronate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000397	0.00045	CcSEcCtD
Risedronate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000389	0.000441	CcSEcCtD
Risedronate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000384	0.000435	CcSEcCtD
Risedronate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000384	0.000434	CcSEcCtD
Risedronate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000381	0.000432	CcSEcCtD
Risedronate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000381	0.000432	CcSEcCtD
Risedronate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000378	0.000428	CcSEcCtD
Risedronate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000362	0.00041	CcSEcCtD
Risedronate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000362	0.000409	CcSEcCtD
Risedronate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000351	0.000398	CcSEcCtD
Risedronate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00035	0.000396	CcSEcCtD
Risedronate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00035	0.000396	CcSEcCtD
Risedronate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000326	0.000369	CcSEcCtD
Risedronate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000317	0.000359	CcSEcCtD
Risedronate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000313	0.000354	CcSEcCtD
Risedronate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000303	0.000343	CcSEcCtD
Risedronate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000331	CcSEcCtD
Risedronate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000281	0.000318	CcSEcCtD
Risedronate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000279	0.000316	CcSEcCtD
Risedronate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000279	0.000316	CcSEcCtD
Risedronate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000277	0.000314	CcSEcCtD
Risedronate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000263	0.000297	CcSEcCtD
